# GeneWerk GmbH

> German biotechnology company

**Wikidata**: [Q100718021](https://www.wikidata.org/wiki/Q100718021)  
**Source**: https://4ort.xyz/entity/genewerk-gmbh

## Summary
GeneWerk GmbH is a German biotechnology company headquartered in Heidelberg. Founded in July 2014, the organization operates as a business entity within the economic landscape of Germany. It maintains an English-language website at genewerk.com to facilitate its commercial and professional activities.

## Key Facts
*   **Entity Type:** GeneWerk GmbH is classified as a business, specifically a biotechnology company.
*   **Headquarters:** The company is based in Heidelberg, Germany.
*   **Inception:** It was founded in July 2014.
*   **Website:** The official website is https://www.genewerk.com/, which operates in English.
*   **National Context:** As a German business, it operates within a sovereign state in Central Europe with a federal parliamentary republic government.
*   **Economic Classification:** It is an instance of a business, defined as an organization undertaking commercial, industrial, or professional activity with the goal of generating profit.
*   **Legal Status:** It functions as a juridical person and an economic entity.

## FAQs
**Where is GeneWerk GmbH located?**
The company is headquartered in Heidelberg, which is a city in the country of Germany.

**When was GeneWerk GmbH established?**
GeneWerk GmbH was founded in July 2014.

**What industry does the company operate in?**
It operates within the biotechnology sector as a business engaged in commercial, industrial, or professional activities.

**What is the company's online presence?**
The company maintains a website at genewerk.com, which is presented in the English language.

**What type of entity is GeneWerk GmbH legally?**
It is a business, which is legally classified as a juridical person and a type of organization.

## Why It Matters
GeneWerk GmbH represents a specific instance of a biotechnology business operating within Germany's robust economic framework. As a business entity, it serves as a fundamental unit of economic activity, mobilizing human capital and property to achieve profit. Its establishment in Heidelberg places it within a major German city known for its scientific and research infrastructure, contributing to the country's strong focus on technology, innovation, and STEM education. By operating as a commercial organization, it participates in the broader industrial and professional landscape that drives Germany's position as a key player in the global economy.

## Notable For
*   **Specialization:** Operating specifically as a biotechnology company within the German market.
*   **Location:** Being headquartered in Heidelberg, a city with a significant reputation for science and research.
*   **Digital Accessibility:** Maintaining an English-language website (genewerk.com) to support its virtual business operations.
*   **Economic Integration:** Functioning as a juridical person within Germany, a country with a GDP of approximately €4.12 trillion and a strong export economy.

## Body

### Corporate Identity and Classification
GeneWerk GmbH is defined as a business, which is an organization or economic entity engaged in commercial, industrial, or professional activities. Structurally, it is classified as a subclass of an organization, an economic entity, and a juridical person. Like other businesses, its primary goal is the generation of profit or economic gain. The entity is composed of key parts, including the enterprise itself, economic activity, the business sector, property, and human capital. It is distinct from a "trading business" (Handelsgewerbe) but falls under the broader umbrella of commercial organizations and enterprises.

### Geographic Location and National Context
The company is headquartered in Heidelberg, Germany. Germany is a sovereign state in Central Europe and a federal parliamentary republic with a population of over 83 million people. The country is known for its political stability, strong economy, and rich cultural heritage. As a German business, GeneWerk GmbH operates under the national motto "Einigkeit und Recht und Freiheit" (Unity and Justice and Freedom) and utilizes the euro as its official currency. Germany is a member of major international organizations, including the United Nations, the European Union, NATO, the G7, and the G20, providing a stable diplomatic and economic environment for the company's operations.

### Establishment and History
GeneWerk GmbH was established in July 2014. This inception date places the company within the modern era of Germany's economic development, following the nation's re-establishment as the Federal Republic of Germany on May 23, 1949. The company's founding aligns with Germany's emphasis on technology and innovation, particularly in sectors like biotechnology. The country has a highly developed education system with a literacy rate of 99% and a strong focus on STEM fields, which supports the workforce required for biotechnology enterprises.

### Digital Presence and Operations
The company operates a virtual business component through its website, genewerk.com. The website is presented in the English language, indicating an international or English-speaking scope for its digital communications. This aligns with the concept of a business being a "union of" brick-and-mortar and virtual business models. By maintaining a digital presence, GeneWerk GmbH leverages global connectivity, which is supported by Germany's extensive transportation and logistics network, including highways, railways, and airports.

### Economic Environment
GeneWerk GmbH operates within Germany's strong and diverse economy, which had a GDP of approximately €4.12 trillion in 2023. The German economy is driven by key sectors such as manufacturing, services, and technology, making it a major exporter of goods and services. The country maintains a robust legal framework and a vibrant startup ecosystem, which are conducive to the growth of businesses like GeneWerk GmbH. Germany's focus on environmental sustainability and climate action also influences the operational context for biotechnology companies in the region.